Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Yerba Mate (Ilex paraguariensis) has been studied for its potential effects on lipid metabolism, including its role in lowering triglyceride levels. Several small human clinical trials and animal studies have investigated these effects. One notable randomized controlled trial published in 2009 found that daily consumption of Mate tea for 40 days significantly reduced serum triglycerides and LDL cholesterol in hyperlipidemic individuals compared to baseline, although the effect size was moderate. Mechanistically, these effects are thought to be related to the polyphenols and saponins in Mate, which may inhibit lipid absorption and improve lipid metabolism. Animal studies have shown similar trends, with reductions in triglycerides and improvements in lipid profiles after Mate administration.

However, the overall strength of the evidence is limited by small sample sizes, relatively short trial durations, and a lack of large-scale, high-quality randomized controlled trials. As such, while preliminary data suggest a possible benefit for triglyceride reduction, the evidence is not robust enough to warrant strong clinical recommendations. Mate has some traditional use in South America for general cardiovascular health, but its specific application for hypertriglyceridemia is primarily supported by early scientific data rather than longstanding traditional use or established clinical guidelines.

More about Mate
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Mate

Products containing Mate